Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Sichuan Cancer Hospital and Institute ×

Sichuan Cancer Hospital and Institute

This institution is selected. Its supporting articles are shown below.

Sichuan Cancer Hospital and Institute1

Articles mentioning Sichuan Cancer Hospital and Institute

1 articles · page 1 of 1

Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

bmjopen · abstract · 2025-10-15 · 2 matching annotations

80.0%

Fujian Medical University Union Hospital Chinese Academy of Medical Sciences Peking Union Medical College Sichuan Cancer Hospital and Institute Shanghai Jiao Tong University School of Medicine Sichuan Cancer Centre camrelizumab

…Zhengzhou University, Henan Cancer Hospital (Zhengzhou, China); Fujian Medical University Union Hospital (Fuzhou, China). Complete information about the study status, r…

Browse institutions

Sichuan Cancer Hospital and Institute

Articles mentioning Sichuan Cancer Hospital and Institute

Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)